Menu
GeneBe

TBC1D4

TBC1 domain family member 4

Basic information

Region (hg38): 13:75283502-75482169

Links

ENSG00000136111NCBI:9882OMIM:612465HGNC:19165Uniprot:O60343AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Diabetes mellitus, noninsulin-dependent 5ARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingEndocrine25043022
Heterozygous carriers may also display mild effects related to glucose metabolism

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the TBC1D4 gene.

  • not provided (47 variants)
  • Inborn genetic diseases (35 variants)
  • not specified (27 variants)
  • TBC1D4-related condition (2 variants)
  • Insulin resistance (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the TBC1D4 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
2
clinvar
2
clinvar
5
clinvar
9
missense
40
clinvar
4
clinvar
7
clinvar
51
nonsense
0
start loss
1
clinvar
1
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
1
clinvar
1
splice region
1
1
non coding
34
clinvar
34
Total 0 0 43 7 46

Variants in TBC1D4

This is a list of pathogenic ClinVar variants found in the TBC1D4 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
13-75286668-C-A Benign (Jun 19, 2021)1273750
13-75286854-G-C not specified Uncertain significance (Dec 18, 2023)3174670
13-75286862-T-C not specified Likely benign (Oct 05, 2016)436949
13-75286865-A-G not specified Likely benign (-)130861
13-75286879-G-C not specified Likely benign (May 02, 2017)436953
13-75286927-T-A not specified Likely benign (-)130860
13-75286993-T-A Benign (Aug 22, 2018)775344
13-75287038-G-GA not specified Benign (Feb 21, 2013)212373
13-75288980-T-C not specified Benign (Sep 05, 2013)130553
13-75289179-G-C Benign (Nov 12, 2018)1240415
13-75292148-G-A not specified Benign (Jun 09, 2021)130552
13-75292197-T-C TBC1D4-related disorder Likely benign (Sep 25, 2020)3057756
13-75292232-A-G not specified Benign (Jul 31, 2018)130544
13-75292518-T-A Benign (Jun 19, 2021)1279343
13-75292525-C-T Benign (Nov 12, 2018)1222510
13-75294562-T-C Benign (Nov 12, 2018)1289397
13-75294705-C-T Benign (Nov 12, 2018)1295485
13-75294942-A-T not specified Uncertain significance (Mar 04, 2024)3174668
13-75295271-A-T Benign (Nov 12, 2018)1236980
13-75299338-A-G not specified Uncertain significance (Dec 20, 2023)3174667
13-75299364-C-T Insulin resistance • not specified Uncertain significance (Jun 21, 2022)562223
13-75299375-G-T not specified Uncertain significance (May 24, 2023)2550766
13-75299455-T-A not specified Uncertain significance (Mar 29, 2023)2513634
13-75299651-G-A Benign (Nov 12, 2018)1271807
13-75302249-C-T not specified Uncertain significance (Nov 30, 2021)2262582

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
TBC1D4protein_codingprotein_codingENST00000377636 21197443
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
8.47e-240.48112461312041248180.000822
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.7006497010.9260.00003978506
Missense in Polyphen274308.460.888283848
Synonymous-0.3642942861.030.00001712494
Loss of Function2.114664.30.7160.00000341746

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.007420.00736
Ashkenazi Jewish0.00009930.0000993
East Asian0.0003910.000389
Finnish0.0004210.000417
European (Non-Finnish)0.0004030.000397
Middle Eastern0.0003910.000389
South Asian0.0003620.000360
Other0.0006600.000659

dbNSFP

Source: dbNSFP

Function
FUNCTION: May act as a GTPase-activating protein for RAB2A, RAB8A, RAB10 and RAB14. Isoform 2 promotes insulin-induced glucose transporter SLC2A4/GLUT4 translocation at the plasma membrane, thus increasing glucose uptake. {ECO:0000269|PubMed:15971998, ECO:0000269|PubMed:18771725, ECO:0000269|PubMed:22908308}.;
Disease
DISEASE: Diabetes mellitus, non-insulin-dependent, 5 (NIDDM5) [MIM:616087]: A multifactorial disorder of glucose homeostasis caused by a lack of sensitivity to the body's own insulin. Affected individuals usually have an obese body habitus and manifestations of a metabolic syndrome characterized by diabetes, insulin resistance, hypertension and hypertriglyceridemia. The disease results in long-term complications that affect the eyes, kidneys, nerves, and blood vessels. {ECO:0000269|PubMed:25043022}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.;
Pathway
Insulin resistance - Homo sapiens (human);Thyroid hormone signaling pathway - Homo sapiens (human);Insulin Signaling;Vesicle-mediated transport;Membrane Trafficking;Translocation of GLUT4 to the plasma membrane;Insulin-mediated glucose transport;Class I PI3K signaling events mediated by Akt (Consensus)

Recessive Scores

pRec
0.106

Intolerance Scores

loftool
0.771
rvis_EVS
1.03
rvis_percentile_EVS
91.12

Haploinsufficiency Scores

pHI
0.223
hipred
Y
hipred_score
0.744
ghis
0.450

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.631

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Tbc1d4
Phenotype
growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); endocrine/exocrine gland phenotype; muscle phenotype; cellular phenotype; homeostasis/metabolism phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hearing/vestibular/ear phenotype; immune system phenotype;

Gene ontology

Biological process
intracellular protein transport;vesicle-mediated transport;negative regulation of vesicle fusion;cellular response to insulin stimulus;activation of GTPase activity
Cellular component
cytosol;vesicle
Molecular function
GTPase activator activity;Rab GTPase binding